Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Merck plans Phase III trials for Keytruda in prostate cancer

Merck is currently studying Keytruda in more than 900 trials. Credit: Merck KGaA, Darmstadt, Germany.



  • Merck plans Phase III trials for Keytruda in prostate cancer

Go Top